Literature DB >> 18769827

[Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].

Hugo Henríquez B1, Marcela Henríquez H, Ximena Carrasco Ch, Paula Rothhammer A, Elena Llop R, Francisco Aboitiz, Francisco Rothhammer E.   

Abstract

BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is a common, highly heritable neurobiological disorder of childhood onset, characterized by hyperactivity, impulsiveness, and/or inattentiveness. AIM: To search for possible associations between dopamine receptor D4 (DRD4) and dopamine transponder 1 (DATl) polymorphisms and ADHD in Chilean families.
MATERIAL AND METHODS: We extended a previous family-based discordant sib pair analysis that included 26 cases diagnosed according to DSM-IV criteria and 25 controls (healthy siblings of cases), adding 14 cases and 11 controls.
RESULTS: Both loci, individually classified as homozygotes or heterozygotes for the DRD4 7-repeat and DATl 10-repeat alleles, did not exhibit genotype frequency differences between affected children and their healthy siblings. However, the simultaneous presence of both DRD4 7-repeat heterozygosity and DATl 10 allele homozygosity was significantly higher (22.5%) in cases (40), compared with (2.8%) unaffected siblings (36), with an odds-ratio of 10.16.
CONCLUSIONS: The genotype combination DRD4/7 heterozygotes and DAT1/10 homozygotes is a high risk factors in Chilean families for ADHD. Increased density of dopamine transporters in ADHD brains, along with abundance of 7-repeat D4 receptors in prefrontal cortex, which is impaired in ADHD patients, make the observed gene-gene interaction worthy of studies to understand the functional basis of ADHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769827     DOI: /S0034-98872008000600005

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  6 in total

1.  Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.

Authors:  Weidong Ji; Ning Li; Kang Ju; Hong Zheng; Chuang Yang; Ping Xu; Silu Chen; Aiai Cao; Xue Chen; Lanting Guo
Journal:  Neurol Sci       Date:  2014-11-04       Impact factor: 3.307

2.  Epistasis between neurochemical gene polymorphisms and risk for ADHD.

Authors:  Ricardo Segurado; Mark A Bellgrove; Francesca Manconi; Michael Gill; Ziarah Hawi
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

3.  Epigenetics in Developmental Disorder: ADHD and Endophenotypes.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum
Journal:  J Genet Syndr Gene Ther       Date:  2011-06-30

Review 4.  Molecular genetics of attention-deficit/hyperactivity disorder: an overview.

Authors:  Tobias Banaschewski; Katja Becker; Susann Scherag; Barbara Franke; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-10       Impact factor: 4.785

5.  Disordered eating in early childhood: DRD4 and DAT1 gene polymorphisms and quality of mother-child interaction.

Authors:  Esterina Pascale; Silvia Cimino; Luca Cerniglia; Arturo Bevilacqua
Journal:  Eat Weight Disord       Date:  2022-05-05       Impact factor: 3.008

6.  Childhood Blood Lead Levels and Symptoms of Attention Deficit Hyperactivity Disorder (ADHD): A Cross-Sectional Study of Mexican Children.

Authors:  Siying Huang; Howard Hu; Brisa N Sánchez; Karen E Peterson; Adrienne S Ettinger; Héctor Lamadrid-Figueroa; Lourdes Schnaas; Adriana Mercado-García; Robert O Wright; Niladri Basu; David E Cantonwine; Mauricio Hernández-Avila; Martha María Téllez-Rojo
Journal:  Environ Health Perspect       Date:  2015-12-08       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.